Medicinski fakultet, Katedra za biohemiju

View Statistics Email Alert RSS Feed
Organization name
Medicinski fakultet, Katedra za biohemiju
Parent OrgUnit
City
Novi Sad
Country
Serbia

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Refined By:
Type:  Other

Results 1-18 of 18 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
11-Feb-2015Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseasesStanimirov, Bojan ; Stankov, Karmen ; Mikov, Momir 
21-Jan-2017Bile acids as novel pharmacological agents: The interplay between gene polymorphisms, epigenetic factors and drug responseNebojša Pavlović ; Bojan Stanimirov ; Momir Mikov 
31-Jan-2005Bioinformatic tools for cancer geneticistsStankov, Karmen 
41-Jan-2014C-KIT signaling in cancer treatmentStankov, Karmen ; Popović, Živko; Mikov, Momir 
51-Jan-2006Cloning of the genes for non-medullary thyroid cancer: Methods and advancesStankov, Karmen ; Romeo G.
61-Jan-2019DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal ImpairmentMikov, Momir ; Pavlović, Nebojša ; Stanimirov, Bojan ; Đanić, Maja ; Goločorbin-Kon, Svetlana ; Stankov, Karmen ; Al-Salami H.
71-Jan-2017Editorial: Discovery and Validation of Drug Targets Through Human Genetics and EpigeneticsStankov, Karmen 
81-Apr-2012Ethical and legal aspects of oncogenomicsStankov, Karmen ; Drašković, Dragan ; Mikov, Momir 
91-Jan-2017Genetic and epigenetic drug targets in myelodysplastic syndromesStankov, Karmen ; Stanković, Danica; Katanić, Jasmina 
101-Dec-2013Genetic and epigenetic factors in etiology of diabetes mellitus type 1Stankov, Karmen ; Benc, Damir ; Drašković, Dragan 
111-Jan-2012The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel diseaseStojancevic M.; Stankov, Karmen ; Mikov, Momir 
121-Oct-2012An insight on differences in availability and reimbursement of orphan medicines among Serbia, Bulgaria and SwedenPavlović, Nebojša ; Stanimirov, Bojan ; Stojančević M.; Paut-Kusturica M.; Stoimenova A.; Goločorbin-Kon, Svetlana ; Mikov, Momir 
131-Jan-2014Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - The role of IkarosWang H.; Ouyang H.; Lai L.; Petrovic-Dovat L.; Stankov, Karmen ; Bogdanovic G.; Dovat S.
141-Feb-2013Pharmacogenetic biomarkers as tools for pharmacoepidemiology of severe adverse drug reactionsStankov, Karmen ; Sabo, Ana ; Mikov, Momir 
151-Jan-2018Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndromeMaja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Karmen Stankov ; Momir Mikov 
161-Dec-2012Pleiotropic functions of bile acids mediated by the farnesoid X receptorStanimirov, Bojan ; Stankov, Karmen ; Mikov, Momir 
171-Jun-2018Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and ProbioticsMomir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami
181-Jan-2009Translational research in complex etiopathogenesis and therapy of hematological malignancies: The specific role of tyrosine kinases signaling and inhibitionStankov, Karmen ; Stankov S.; Popović S.